These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 3786944)

  • 1. Dose and sex-dependent disposition of ketoconazole in rats.
    Sjöberg P; Ekman L; Lundqvist T
    Arch Toxicol; 1988; 62(2-3):177-80. PubMed ID: 3196151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.
    Meredith CG; Maldonado AL; Speeg KV
    Drug Metab Dispos; 1985; 13(2):156-62. PubMed ID: 2859162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver.
    Sheets JJ; Mason JI
    Drug Metab Dispos; 1984; 12(5):603-6. PubMed ID: 6149911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms.
    Shayeganpour A; El-Kadi AO; Brocks DR
    Drug Metab Dispos; 2006 Jan; 34(1):43-50. PubMed ID: 16204463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.
    Tsunoda SM; Velez RL; von Moltke LL; Greenblatt DJ
    Clin Pharmacol Ther; 1999 Nov; 66(5):461-71. PubMed ID: 10579473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.
    Lee JI; Chaves-Gnecco D; Amico JA; Kroboth PD; Wilson JW; Frye RF
    Clin Pharmacol Ther; 2002 Dec; 72(6):718-28. PubMed ID: 12496753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of chronic oral ketoconazole on in vivo drug metabolism in the rat.
    Jiritano L; Bortolotti A; Bonati M
    Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):173-80. PubMed ID: 3786944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketoconazole and fluconazole drug interactions.
    Baciewicz AM; Baciewicz FA
    Arch Intern Med; 1993 Sep; 153(17):1970-6. PubMed ID: 8357281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug metabolism and effects of carcinogens in cultured hepatic cells.
    Sirica AE; Pitot HC
    Pharmacol Rev; 1979 Sep; 31(3):205-28. PubMed ID: 399684
    [No Abstract]   [Full Text] [Related]  

  • 10. Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use.
    Van Tyle JH
    Pharmacotherapy; 1984; 4(6):343-73. PubMed ID: 6151171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional effects on hepatic drug metabolism in the elderly.
    Anderson KE
    Prog Clin Biol Res; 1990; 326():263-77. PubMed ID: 2405422
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic drug interactions with phenytoin (Part II).
    Nation RL; Evans AM; Milne RW
    Clin Pharmacokinet; 1990 Feb; 18(2):131-50. PubMed ID: 2180613
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.